- Home
- MANH vs CADL Comparison
MANH vs CADL Comparison
Compare MANH & CADL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MANH
- CADL
- Stock Information
- Founded
- MANH 1990
- CADL 1999
- Country
- MANH United States
- CADL United States
- Employees
- MANH N/A
- CADL N/A
- Industry
- MANH Computer Software: Prepackaged Software
- CADL Biotechnology: Pharmaceutical Preparations
- Sector
- MANH Technology
- CADL Health Care
- Exchange
- MANH Nasdaq
- CADL Nasdaq
- Market Cap
- MANH N/A
- CADL 234.8M
- IPO Year
- MANH 1998
- CADL 2021
- Fundamental
- Price
- MANH $198.71
- CADL $4.99
- Analyst Decision
- MANH Buy
- CADL Strong Buy
- Analyst Count
- MANH 9
- CADL 5
- Target Price
- MANH $208.88
- CADL $21.40
- AVG Volume (30 Days)
- MANH 665.5K
- CADL 914.4K
- Earning Date
- MANH 07-22-2025
- CADL 08-12-2025
- Dividend Yield
- MANH N/A
- CADL N/A
- EPS Growth
- MANH 14.38
- CADL N/A
- EPS
- MANH 3.50
- CADL N/A
- Revenue
- MANH $1,050,587,000.00
- CADL N/A
- Revenue This Year
- MANH $3.90
- CADL N/A
- Revenue Next Year
- MANH $7.11
- CADL N/A
- P/E Ratio
- MANH $56.80
- CADL N/A
- Revenue Growth
- MANH 9.18
- CADL N/A
- 52 Week Low
- MANH $140.81
- CADL $3.79
- 52 Week High
- MANH $312.60
- CADL $14.60
- Technical
- Relative Strength Index (RSI)
- MANH 61.43
- CADL 45.92
- Support Level
- MANH $194.52
- CADL $4.73
- Resistance Level
- MANH $200.46
- CADL $5.24
- Average True Range (ATR)
- MANH 4.50
- CADL 0.29
- MACD
- MANH 0.50
- CADL -0.01
- Stochastic Oscillator
- MANH 88.99
- CADL 46.36
About CADL Candel Therapeutics Inc.
Candel Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing viral immunotherapies to help patients fight cancer. The company has established two clinical-stage viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.